Ładuje się......
Cardiovascular Safety of VEGF-Targeting Therapies: Current Evidence and Handling Strategies
Treatment with the angiogenesis inhibitors bevacizumab, sunitinib, and sorafenib as single agents or in combination with conventional chemotherapy is becoming a cornerstone of modern anticancer therapy. However, the potential toxicity of these drugs, mainly to the cardiovascular system, is still bei...
Zapisane w:
| Główni autorzy: | , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
AlphaMed Press
2010
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3228010/ https://ncbi.nlm.nih.gov/pubmed/20547589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2009-0235 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|